Skip to content

Clinical trials

Carcinoma, Ovarian Epithelial trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Country / region: Brazil Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20171
20201
20211
20221
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Active, not recruiting3
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Amgen1
CanariaBio Inc.1
Daiichi Sankyo1
Instituto do Cancer do Estado de São Paulo1
Merck Sharp & Dohme LLC1
Recepta Biopharma1
pharmaand GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial10
Fallopian Tube Neoplasms7
Ovarian Neoplasms6
Cholangiocarcinoma2
Adenocarcinoma of Lung1
Adrenal Gland Neoplasms1
Anus Neoplasms1
Biliary Tract Neoplasms1
Carcinoma, Adenoid Cystic1
Carcinosarcoma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.